Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. | Read by QxMD (original) (raw)
Journal Article
Practice Guideline
Review
Alan Menter, Bruce E Strober, Daniel H Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W Armstrong, Cody Connor, Kelly M Cordoro, Dawn M R Davis, Boni E Elewski, Joel M Gelfand, Kenneth B Gordon, Alice B Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L Leonardi, Jason Lichten, Henry W Lim, Nehal N Mehta, Amy S Paller, Sylvia L Parra, Arun L Pathy, Reena N Rupani, Michael Siegel, Emily B Wong, Jashin J Wu, Vidhya Hariharan, Craig A Elmets
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.
We have located links that may give you full text access.
All material on this website is protected by copyright, Copyright © 1994-
2024
by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our
and
